GlassScriptPhysician profile
Erin Porter
NPI 1952625287
$2,084.69
in general payments reported to CMS, 2019-2025
16 companies · $698 in 2025
The $698 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $417 · 2023: $218 · 2024: $606 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $728.27 | 2021-2025 | Lifevest |
| Abbott Laboratories | $364.08 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $261.67 | 2022-2025 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $155.03 | 2022-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $113.74 | 2021-2024 | Watchman Flx, Watchman Access System |
| Cvrx, INC. | $90.63 | 2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $79.99 | 2022-2024 | Xarelto |
| Pfizer INC. | $60.58 | 2021 | |
| Esperion Therapeutics, INC. | $47.34 | 2023-2024 | Nexletol |
| Kestra Medical Technology Services, INC. | $38.27 | 2022-2023 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.99 | 2022-2023 | Jardiance |
| Amgen INC. | $27.11 | 2021 | |
| Abiomed | $22.33 | 2024 | Impella |
| Novartis Pharmaceuticals Corporation | $22.26 | 2025 | |
| Teleflex LLC | $19.19 | 2025 | Guideliner |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.21 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.